DRKS00016416
Recruiting
Not Applicable
Prospective evaluation of detection of circulating tumor DNA (ctDNA) to predict recurrence after definitive therapy of localized stage lung cancer (PREDICT) - PREDICT
Klinik für Kardiologie und Pneumologie, Klinikum Esslingen0 sites180 target enrollmentApril 8, 2019
Conditionslung cancer nsclc and sclc
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- lung cancer nsclc and sclc
- Sponsor
- Klinik für Kardiologie und Pneumologie, Klinikum Esslingen
- Enrollment
- 180
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with NSCLC stage I\-IVA with planned curative therapy. SCLC stage I\-IIIC with planned curative therapy.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A prospective study of measurement of circulating tumor DNA during neoadjuvant chemotherapy for esophageal cancerresectable advanced esophageal cancerJPRN-UMIN000029788Wakayama medical university40
Completed
Not Applicable
Evaluation of the efficacy of the detection of the significant cancer and the safety in MRI-TRUS fusion image-guided prostate biopsy: multi-institutional study in Japaprostate cancer suspectedJPRN-UMIN000042397Tokai University400
Completed
Not Applicable
Evaluation of AI-assisted software for colonoscopycolorectal lesionJPRN-UMIN000040677Digestive Disease Center, Showa University Northern Yokohama Hospital2,261
Recruiting
Phase 2
Exploratory study to evaluate the detection ability of photodynamic endoscopic imaging for differentiated gastric cancer and gastric adenomaJPRN-jRCTs061230040Isomoto Hajime80
Completed
Not Applicable
Prospective evaluation of the DEtection rate of clinically significant PROstate cancer by mpMRI and PSMA-PET/CT fusion biopsyProstate cancerC61Malignant neoplasm of prostateDRKS00024134Klinik und Poliklinik für Urologie und Kinderurologie Universitätsklinikum Bonn246